Over the past 20 years, Dr. Marisa Weiss has treat thousands of women diagnose with breast cancer. But in April of 2010, the creator of the website breastcancer.org found herself on the other side of the investigative table. After a routine mammogram, she was diagnose with a breast tumor. "When it happen to me, it was a shock," the oncologist tells Terry Gross. "I was a very busy person and during a very busy day like anyone else, I had to rush up to the mammography department, get all the clothes off, wait in that gown, wait to be called and I thought it was now going to be like any other year."
The radiologist who inspect Weiss' films told her that he saw something worrisome and was not sure what it was. "Those words were grave words," she recalls. "And I got an meeting to come back the after that day." After another mammogram inveterate calcifications in her breast, Weiss had an MRI a more responsive diagnostic test for dense breasts like hers. "After the MRI, I came out and looked at the faces of the radiology technicians who function the machines and they would not look at me," she says.
"They were shun my look. So I know then that it was severe. And then I go from there to the radiology reading room to meet with a radiologist who pull the images fresh up on the screen and like a glow bulb there it was, a tumor in my left breast that was obviously a cancer." Weiss is lucky. Her cancer was discovered early on and her prognosis is excellent. She says without a custom mammogram, she might not have been so fortunate. In 2009, a report issue by the U.S. preventive Services job Force said that mammograms were needless for women under 50 and women over 50 only needed mammograms each other year.
useful links : transport rankings
New researches suggest that lung cancer in people who have never smoked may be a dissimilar disease than it is in smokers. Scientists compare the genetic characteristics of lung cancer tumors in 30 people who not at all smoked to tumors in 53 smokers or former smokers. The tumors of people who had not at all smoked had twice as many DNA abnormalities as people who were present or former smokers, said study author Kelsie Thu, a doctoral applicant at the British Columbia Cancer Research Centre in Vancouver. "This is telling there might be incredible different going on with tumors in never smokers," Thu said. "If we find out lung cancer in never smokers is a different disease and we can recognize what those differences are, maybe we can design specific therapies that goal the genetic alterations in never-smokers and improve the prognosis." The study was to be obtainable Monday at the American Association of Cancer Research's annual meeting, in Philadelphia. Lung cancer is the foremost cause of cancer death in the America for men and woman, according to the American Cancer Society. Lung cancer will kill a predictable 157,000 Americans this year. But it's not now smokers who get it lung cancer is the seventh foremost cause of cancer deaths among people who have not at all smoked, Thu said. Dana Reeve, wife of the late Christopher Reeve, died in 2006 at age 44 from lung cancer. She had not at all smoked. Prior research has oblique that lung cancer tumors in never-smokers are different than the tumors in smokers. Compare to former and present smokers with lung cancer, never-smokers with lung cancer lean to be diagnosed younger, are more likely to be women and are extra likely to have adenocarcinomas, the majority common type of cancer. Every one of the lung cancer patients in the study had adenocarcinoma. People who never smoked are also more likely to have a change in the epidermal growth issue receptor (EGFR) gene.
Prolonging first-line chemotherapy in metastatic breast cancer delays disease progression and rate of death, according to the results of a meta-analysis presented here at the 35th European Society for Medical Oncology Congress. "Our review suggests that longer duration of first-line chemotherapy, until disease progression or for a predetermined number of cycles, shows a 36% decrease in the rate of disease progression," said lead author Alessandra Gennari, MD, a medical oncologist from Galliera Hospital in Genova, Italy.
"This was clinically significant and statistically significant, and there was a 9% decrease in the rate of death," she told Medscape Medical News. The optimum duration of first-line chemotherapy is motionless poorly defined. Dr .Gennari explained that in the United States, chemotherapy is regularly administered until disease progression, but in Europe, practice is unclear. "Many European oncologists stop chemotherapy after a predetermined number of cycles, with period of chemotherapy dictated by patient tolerability, responsiveness, and physician preferences."
"The first thing patients ask when they get chemotherapy is, 'How long must this treatment continue?' and the best reply we can give is, 'As long as you can cope with it,' " Dr. Gennari emphasized. "We know that if we stop chemotherapy then the disease will development, but if we prolong therapy then, of course, disease will progress sooner or later, but we know it will really be later," The US National complete Cancer Network guidelines state that: "Due to the lack of overall endurance differences, the use of protracted versus shorter chemotherapy needs to be weighted beside the detrimental effects of incessant chemotherapy on overall quality of life."
useful links :
transport rankings
Breast cancer is one of the mainly common cancers among women in New York State. Each year, about 13,900 women are diagnose with breast cancer and about 2,900 women die from the disease in New York State. It is estimated that one in eight women will expand breast cancer sometime during her life. Men also get breast cancer, but it is extremely rare. About 150 men are diagnose with breast cancer every year in New York State.
Breast cancer is more ordinary among older women. The risk for receiving breast cancer increases with age. More than three-quarters of women who find breast cancer are over the age of fifty. White women are more likely to get breast cancer than Black women. Also, women with high socioeconomic rank are more likely to get breast cancer. Scientists believe this may be connected to having their first child at an older age, fewer pregnancies, diet and possibly other factors shared by women in higher income groups.
Most women who expand breast cancer have no risk factors. Among women with normal risk, breast cancer cannot be prevented. Mammograms, breast self-examination, and test of your breasts by your health care provider increase the chances that breast cancer will be diagnosed early. Among women who have advanced than average risk, certain drugs may be useful in preventing breast cancer. All women should discuss their risk and screening or avoidance options with their health care provider.
useful links:
transport rankings
